These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 15544694

  • 1. Symptomatic bone disorders in HIV-infected patients: incidence in the Aquitaine cohort (1999-2002).
    Martin K, Lawson-Ayayi S, Miremont-Salamé G, Blaizeau MJ, Balestre E, Lacoste D, Ragnaud JM, Malvy D, Dupon M, Mercié P, Schaeverbeke T, Haramburu F, Dabis F, Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    HIV Med; 2004 Nov; 5(6):421-6. PubMed ID: 15544694
    [Abstract] [Full Text] [Related]

  • 2. Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus: Aquitaine Cohort, France, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
    Thiessard F, Morlat P, Marimoutou C, Labouyrie E, Ragnaud JM, Pellegrin JL, Dupon M, Dabis F.
    Cancer; 2000 Apr 01; 88(7):1696-702. PubMed ID: 10738229
    [Abstract] [Full Text] [Related]

  • 3. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
    Bolhaar MG, Karstaedt AS.
    Clin Infect Dis; 2007 Jul 15; 45(2):254-60. PubMed ID: 17578788
    [Abstract] [Full Text] [Related]

  • 4. Intermittent episodes of detectable HIV viremia in patients receiving nonnucleoside reverse-transcriptase inhibitor-based or protease inhibitor-based highly active antiretroviral therapy regimens are equivalent in incidence and prognosis.
    Sungkanuparph S, Overton ET, Seyfried W, Groger RK, Fraser VJ, Powderly WG.
    Clin Infect Dis; 2005 Nov 01; 41(9):1326-32. PubMed ID: 16206110
    [Abstract] [Full Text] [Related]

  • 5. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C, Dupon M, Lavignolle-Aurillac V, Barthe N, Lawson-Ayayi S, Mehsen N, Mercié P, Morlat P, Thiébaut R, Dabis F, Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    AIDS; 2008 Jan 30; 22(3):395-402. PubMed ID: 18195566
    [Abstract] [Full Text] [Related]

  • 6. Osteonecrosis in six HIV-infected patients receiving highly active antiretroviral therapy.
    Molia AC, Strady C, Rouger C, Beguinot IM, Berger JL, Trenque TC.
    Ann Pharmacother; 2004 Dec 30; 38(12):2050-4. PubMed ID: 15507502
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for osteonecrosis in HIV-infected patients: impact of treatment with combination antiretroviral therapy.
    Mary-Krause M, Billaud E, Poizot-Martin I, Simon A, Dhiver C, Dupont C, Salmon D, Roudiere L, Costagliola D, Clinical Epidemiology Group of the French Hospital Database.
    AIDS; 2006 Aug 01; 20(12):1627-35. PubMed ID: 16868444
    [Abstract] [Full Text] [Related]

  • 8. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO, Salemović D, Ranin J, Pesić I, Zerjav S, Djurković-Djaković O.
    HIV Med; 2007 Mar 01; 8(2):75-9. PubMed ID: 17352762
    [Abstract] [Full Text] [Related]

  • 9. Fibrates or statins and lipid plasma levels in 245 patients treated with highly active antiretroviral therapy. Aquitaine Cohort, France, 1999-2001.
    Bonnet F, Balestre E, Thiébaut R, Mercié P, Dupon M, Morlat P, Dabis F, Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
    HIV Med; 2004 May 01; 5(3):133-9. PubMed ID: 15139977
    [Abstract] [Full Text] [Related]

  • 10. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.
    Ledergerber B, Furrer H, Rickenbach M, Lehmann R, Elzi L, Hirschel B, Cavassini M, Bernasconi E, Schmid P, Egger M, Weber R, Swiss HIV Cohort Study.
    Clin Infect Dis; 2007 Jul 01; 45(1):111-9. PubMed ID: 17554711
    [Abstract] [Full Text] [Related]

  • 11. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
    Corral I, Quereda C, Moreno A, Pérez-Elías MJ, Dronda F, Casado JL, Muriel A, Masjuán J, Alonso-de-Leciñana M, Moreno S.
    Cerebrovasc Dis; 2009 Jul 01; 27(6):559-63. PubMed ID: 19390181
    [Abstract] [Full Text] [Related]

  • 12. Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus.
    Guo JJ, Jang R, Louder A, Cluxton RJ.
    Pharmacotherapy; 2005 Aug 01; 25(8):1044-54. PubMed ID: 16207094
    [Abstract] [Full Text] [Related]

  • 13. Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus.
    Monier P, McKown K, Bronze MS.
    Clin Infect Dis; 2000 Dec 01; 31(6):1488-92. PubMed ID: 11096017
    [Abstract] [Full Text] [Related]

  • 14. Bone disorders in human immunodeficiency virus infection.
    Glesby MJ.
    Clin Infect Dis; 2003 Dec 01; 37 Suppl 2():S91-5. PubMed ID: 12942380
    [Abstract] [Full Text] [Related]

  • 15. Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study.
    Young J, Rickenbach M, Weber R, Furrer H, Bernasconi E, Hirschel B, Tarr PE, Vernazza P, Battegay M, Bucher HC.
    Antivir Ther; 2005 Dec 01; 10(1):73-81. PubMed ID: 15751765
    [Abstract] [Full Text] [Related]

  • 16. Avascular necrosis in HIV-infected patients: a case-control study from the Aquitaine Cohort, 1997-2002, France.
    Lawson-Ayayi S, Bonnet F, Bernardin E, Ragnaud JM, Lacoste D, Malvy D, Blaizeau MJ, Miremont-Salamé G, Dupon M, Mercié P, Dabis F, Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    Clin Infect Dis; 2005 Apr 15; 40(8):1188-93. PubMed ID: 15791521
    [Abstract] [Full Text] [Related]

  • 17. Clinical evidence of interaction between itraconazole and nonnucleoside reverse transcriptase inhibitors in HIV-infected patients with disseminated histoplasmosis.
    Andrade RA, Evans RT, Hamill RJ, Zerai T, Giordano TP.
    Ann Pharmacother; 2009 May 15; 43(5):908-13. PubMed ID: 19401476
    [Abstract] [Full Text] [Related]

  • 18. Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment response.
    Fardet L, Mary-Krause M, Heard I, Partisani M, Costagliola D, French Hospital Database on HIV.
    HIV Med; 2006 Nov 15; 7(8):520-9. PubMed ID: 17105511
    [Abstract] [Full Text] [Related]

  • 19. Osteonecrosis in patients with human immunodeficiency virus type 1 infection in Taiwan.
    Ho YC, Shih TT, Lin YH, Hsiao CF, Chen MY, Hsieh SM, Sheng WH, Sun HY, Hung CC, Chang SC.
    Jpn J Infect Dis; 2007 Nov 15; 60(6):382-6. PubMed ID: 18032839
    [Abstract] [Full Text] [Related]

  • 20. Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine.
    Thiébaut R, Daucourt V, Mercié P, Ekouévi DK, Malvy D, Morlat P, Dupon M, Neau D, Farbos S, Marimoutou C, Dabis F.
    Clin Infect Dis; 2000 Dec 15; 31(6):1482-7. PubMed ID: 11096016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.